ELEV logo

Elevation Oncology, Inc. Common stock


ELEV: Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.


Show ELEV Financials

Consumer Interest
SEC Filings

Recent trades of ELEV by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by ELEV's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of ELEV in WallStreetBets Daily Discussion


Recent insights relating to ELEV

CNBC Recommendations

Recent picks made for ELEV stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ELEV

Corporate Flights

Flights by private jets registered to ELEV